Key statistics
As of last trade Trevi Therapeutics Inc (TRVI:NMQ) traded at 3.47, -13.25% below its 52-week high of 4.00, set on Mar 21, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.51 |
---|---|
High | 3.57 |
Low | 3.42 |
Bid | 3.46 |
Offer | 3.49 |
Previous close | 3.50 |
Average volume | 403.77k |
---|---|
Shares outstanding | 72.59m |
Free float | 71.69m |
P/E (TTM) | -- |
Market cap | 254.07m USD |
EPS (TTM) | -0.3879 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 18:06 BST.
More ▼
- Trevi Therapeutics Announces Oral Presentation on Data from Ph2a CANAL Trial at the European Respiratory Society Congress 2024
- Trevi Therapeutics to Participate in September Investor and Medical Conferences
- Trevi Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates Reaffirming Clinical Trial Guidance
- Trevi Therapeutics to Report Second Quarter 2024 Financial Results and Provide a Corporate Update on August 8, 2024
- Trevi Therapeutics to Participate in Upcoming Investor and Healthcare Events
More ▼